Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity

Published:2019-10 Issue: Volume:179 Page:196-207
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Diao Peng-Cheng,Lin Wei-Yuan,Jian Xie-Er,Li Yan-Hong,You Wen-Wei,Zhao Pei-Liang

Funder

Natural Science Foundation of Guangdong Province

Science and Technology Program of Guangzhou City, China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference33 articles.

1. Cell cycle, CDKs and cancer: a changing paradigm;Malumbres;Nat. Rev. Canc.,2009

2. Cell cycle proteins as promising targets in cancer therapy;Otto;Nat. Rev. Canc.,2017

3. Recent development of CDK inhibitors: an overview of CDK/inhibitor co-crystal structures;Cheng;Eur. J. Med. Chem.,2019

4. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma;Liu;BMC Canc.,2016

5. TFP5 prevents 1-methyl-4-phenyl pyridine ion-induced neurotoxicity in mouse cortical neurons;Zhang;Exp. Ther. Med.,2016

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies;European Journal of Medicinal Chemistry;2024-12

2. Recent Development of CDK2 Inhibitors as Anticancer Drugs: An Update (2015–2023);Pharmaceutical Fronts;2024-09-03

3. Approaches for the discovery of cinnamic acid derivatives with anticancer potential;Expert Opinion on Drug Discovery;2024-08-06

4. Investigating the anticancer properties of six benzothiazolopyrimidine derivatives on colon carcinoma cells, in vitro and in vivo;Journal of Biochemical and Molecular Toxicology;2024-08

5. Unveiling the promise of pyrimidine-modified CDK inhibitors in cancer treatment;Bioorganic Chemistry;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3